Related Experiment Video
Updated: Jul 19, 2026
08:33
Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
Published on: June 25, 2019
Skin biopsies demonstrate MPZ splicing abnormalities in Charcot-Marie-Tooth neuropathy 1B
1Department of Neurology, University of Kentucky, Lexington, KY 40536, USA.
Neurology
|October 13, 2006
Summary
Intronic mutations in myelin protein zero (MPZ) disrupt splicing, causing Charcot-Marie-Tooth neuropathy 1B (CMT1B). This study identified a specific MPZ mutation affecting splicing and nerve function.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Charcot-Marie-Tooth neuropathy 1B (CMT1B) is a demyelinating peripheral neuropathy.
- The myelin protein zero (MPZ) gene is a known cause of CMT1B.
- The role of intronic mutations in MPZ-related neuropathy is not fully understood.
Observation:
- A family presented with late-onset neuropathy and mildly slowed nerve conduction velocities.
- A specific intronic mutation (c.614 + 2T>G) in the MPZ gene was identified, affecting a critical splicing site.
Findings:
- The identified MPZ intronic mutation disrupts normal MPZ splicing, leading to exon skipping and a frameshift.
- Despite splicing abnormalities, MPZ protein levels were normal in nerves, indicating correct transport to compact myelin.
Implications:
- Intronic mutations in MPZ can cause CMT1B through aberrant splicing.
- Certain MPZ mutations might contribute to neuropathy via interactions with wild-type MPZ in the myelin extracellular space.
